18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3514 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

A61P 11/00 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

A61P 11/06 (2006.01) EP 2<strong>09</strong>2941 Drug releasing coatings for medical devices<br />

A61P 11/06 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />

A61P 11/06 (2006.01) EP 2<strong>09</strong>7406 * HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS<br />

A61P 13/08 (2006.01) EP 1935415 Treatment of androgen-deprivation induced osteoporosis<br />

A61P 13/10 (2006.01) EP 2<strong>09</strong>9462 * PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATORY<br />

DISEASES OF THE UROGENITAL TRACT<br />

A61P 13/12 (2006.01) EP 2086535 * ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE TREATMENT OF SYSTEMIC<br />

DISEASES IN CATS<br />

A61P 13/12 (2006.01) EP 2<strong>09</strong>9472 * INTRA-VASCULAR KIDNEY GENE THERAPY WITH PLASMID ENCODING BMP-7<br />

A61P 15/00 (2006.01) EP 2086544 * USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL<br />

DYSFUNCTION<br />

A61P 15/00 (2006.01) EP 2086548 * USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A<br />

AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION<br />

A61P 15/00 (2006.01) EP 2086933 * NOVEL INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND<br />

PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br />

A61P 15/00 (2006.01) EP 2<strong>09</strong>4275 * METHODS AND FORMULATIONS FOR IMPROVED BIOAVAILABILITY OF<br />

ANTIPROGESTINS<br />

A61P 15/06 (2006.01) EP 2<strong>09</strong>1555 * USE OF IL-27 AGONISTS TO REDUCE IMMUNE MEDIATED ABORTION<br />

A61P 15/10 (2006.01) EP 2089392 * 3-(DIHYDRO-1H-PYRAZOLO Ý4,3-D¨PYRIMIDIN-5-YL)-4-<br />

PROPOXYBENZENESULFONAMIDE DERIVATIVES AND METHODS OF USE<br />

A61P 15/10 (2006.01) EP 2<strong>09</strong>4285 * SPECIAL EXTRACT, AND USE THEREOF FOR THE PREVENTION OF CYCLIC GUANOSINE<br />

MONOPHOSPHATE (CGMP) DECOMPOSITION<br />

A61P 17/02 (2006.01) EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES<br />

A61P 17/02 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />

A61P 17/04 (2006.01) EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES<br />

A61P 17/14 (2006.01) EP 2<strong>09</strong>9474 * USE OF GHRELIN TO REVERSE HAIR LOSS<br />

A61P 17/14 (2006.01) EP 2100588 * PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALOPECIA<br />

A61P 19/00 (2006.01) EP 2<strong>09</strong>7406 * HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS<br />

A61P 19/00 (2006.01) EP 2<strong>09</strong>74<strong>09</strong> * 2-SUBSTITUTED-6-HETEROCYCLIC PYRIMIDONE DERIVATIVES AS TAU PROTEIN<br />

KINASE 1 INHBITORS<br />

A61P 19/02 (2006.01) EP 2<strong>09</strong>4708 * A PYRROLOPYRAZIN AS SYK-KINASE INHIBITOR<br />

A61P 19/02 (2006.01) EP 2<strong>09</strong>7406 * HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS<br />

A61P 21/00 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />

DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />

A61P 25/00 (2006.01) EP 2086933 * NOVEL INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND<br />

PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br />

A61P 25/00 (2006.01) EP 2089011 * TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS<br />

A61P 25/00 (2006.01) EP 2089015 * METHODS FOR TREATING DISRUPTIVE BEHAVIOR DISORDERS<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>1942 * SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINE<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>4690 * 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>4701 * COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>4703 * NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE SELECTIVE AMIDES OF<br />

DIAZABICYCLOALKANES<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>4706 * PREPARATION THEREOF AND USE OF SAME AS CANNABINOID CB1 RECEPTOR<br />

LIGANDS<br />

SUBSTITUTED 2,5-DFFLYDRO-3H-PYRAZOLO[4,3-C]PYRIDAZIN-3-ONE DERIVATIVES,<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>74<strong>09</strong> * 2-SUBSTITUTED-6-HETEROCYCLIC PYRIMIDONE DERIVATIVES AS TAU PROTEIN<br />

KINASE 1 INHBITORS<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>7415 * 8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE A2A RECEPTOR ANTAGONISTS<br />

A61P 25/00 (2006.01) EP 2<strong>09</strong>9766 * PYRAZOLE DERIVATIVES AS NON-STEROIDAL GLUCOCORTICOID RECEPTOR LIGANDS<br />

A61P 25/02 (2006.01) EP 2<strong>09</strong>4265 * PYRROLOY[1,2-A]IMIDAZOLEDIONE EFFECTIVE IN THE TREATMENT OF PERIPHERAL<br />

NEUROTOXICITY INDUCED BY CHEMOTHERAPEUTIC AGENTS<br />

A61P 25/02 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />

A61P 25/04 (2006.01) EP 2<strong>09</strong>4705 * AZABICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS<br />

A61P 25/04 (2006.01) EP 2<strong>09</strong>7083 * DOSAGE FORMS AND CO-ADMINISTRATION OF AN OPIOID AGONIST AND AN OPIOID<br />

ANTAGONIST<br />

A61P 25/08 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR<br />

ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT<br />

A61P 25/08 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />

A61P 25/14 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />

DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />

A61P 25/14 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />

A61P 25/16 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />

DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />

A61P 25/16 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />

A61P 25/16 (2006.01) EP 2<strong>09</strong>7372 * PROCESS FOR THE PREPARATION OF MEMANTINE AND ITS HYDROCHLORIC ACID<br />

SALT FORM<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!